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target in OA. No simple test for BCP crystals is currently available
and their detection is difﬁcult due to their small size (nm) and the
complexity of the synovial ﬂuid (SF) samples in which they are
found. BCP crystals usually remain undetected under conven-
tional light microscopy. Unlike other high-resolution microscopic
and spectroscopic techniques, atomic force microscopy (AFM)
and Raman spectroscopy offer the advantage of portability, sim-
plicity and relatively inexpensive instrumentation. The aim of our
group is to develop novel analytical methods for the detection of
BCP microcrystals in SF samples based on AFM, Raman and
colorimetry.
Methods: Spiked samples were prepared by adding synthetic
BCP crystals into control (crystal-free) synovial ﬂuid in concen-
trations found in-vivo. Patient samples were aspirated from the
affected joints (mainly knees and shoulders) of patients with OA.
Control SF samples were either from the knee joints of patients
with early rheumatoid arthritis since these synovial ﬂuid samples
rarely contain BCP crystals or from sports injury knee patients
e.g. patients undergoing arthroscopy. AFM data was collected on
a AFM microscope (Molecular Imaging) on “tapping mode”. Ra-
man measurements were performed on a µ-Raman microscope
(785 nm excitation, Renishaw) on synthetic BCP crystals as well
as on spiked, OA and control SF samples. Colorimetric testing
was carried out by exposing SF samples to a number of crystal-
speciﬁc stains (e.g. alizarin, molybdate blue, o-cresolphthalein
complexone).
Results: AFM revealed the presence of small spheroids of
inorganic-like material of the size expected (nm) of BCP crystals
in samples from patients with severe OA. These features were
not observed in control SF samples. Raman spectral features
indicated that there are certain marker bands that are speciﬁc
to the BCP crystals (such as the phosphate stretching mode
at 960cm-1) which are absent in Raman spectra of SF contain-
ing calcium pyrophosphate dehydrate (CPPD) and monosodium
urate (MSU) crystals. Furthermore, CPPD and MSU also showed
speciﬁc signature modes at 1043 and 1068 cm-1 respectively.
Colorimetric testing indicated the presence of BCP in OA SF,
and could distinguish between BCP, CPPD, MSU and calcium
oxalate crystals.
Conclusions: All three approaches offer potential routes to-
wards a simple and objective diagnostic test for the detection of
BCP crystals in SF as a tool for improved diagnosis and char-
acterisation of osteoarthritis. Furthermore, we believe that these
techniques would be particularly suitable for point-of-care and
clinical applications.
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Purpose: Ultrasonography (US) has proved more sensitive than
clinical exploration for synovitis detection and has been used
successfully as therapeutic monitoring system in rheumatoid
arthritis in numerous published studies.
Chondroitin sulfate (CS) is an important constituent of most ver-
tebrate tissues. CS belongs to the group of glycosaminoglycans,
important structural constituents of cartilage extracellular matrix.
Controlled clinical trials evidence the symptomatic efﬁcacy and
safety of this drug in osteoarthritic patients.
Recently, CS has also proved to be effective in patients with
OA and synovitis (data from the Glucosamine and Chondroitin
Arthritis Intervention Trial -GAIT-). In this study, synovitis assess-
ment was conducted by means of clinical exploration. The aim
of the present study was to monitor by US the efﬁcacy of CS in
patients with OA and associated synovitis.
Methods: An observational study monitored with US for 6
months was conducted in 20 patients with OA and unilateral
knee synovitis, deﬁned according to OMERACT criteria 2004.
Among all patients, 9 presented grade 2 OA according to the
Kellgren & Lawrence (KL) scale and 11 presented KL grade 3.
All patients received treatment with 800 mg CS/day. Ultrasono-
graphic controls were conducted at baseline and after 1, 3 and 6
months by a single observer specialized in US. The contralateral
knee was used as control.
Results: In 8 out of the 9 patients with KL grade 2 and in 7
out of the 11 patients with KL grade 3 a progressive remission
of synovitis was observed, evident from the 3rd month onwards.
None of the contralateral knees developed synovitis. In one
patient with KL grade 2 there was no complete remission, with
persisting effusion, though less severe than at baseline. In 5
patients with KL grade 3, full doses of NSAIDs were necessary
for a period of 21 days.
Conclusions: US allows synovitis detection in osteoarthritic
patients and can be used as a therapeutic monitoring system of
the inﬂammatory activity in OA. CS at the dose of 800 mg/day
is an effective treatment to control synovitis in patients with OA,
conﬁrming previous data from the literature.
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Purpose: Purpose: To compare the 3D cartilage segmentation
performance of a quadrature transmit-receive extremity coil (USA
Instruments (Aurora OH)) and a phased array coil with quadrature
transmit, 8 channel receive extremity coil (InVivo Corporation
(Orlando FL)) using semi-automated analysis methods.
Methods: Measurements of cartilage volume, thickness, and
surface area were made using 10 (5 normal and 5 OA) subjects.
Eight subjects had unilateral knee acquisitions and 2 received a
bilateral scan, which provided a total of 12 knees for analysis.
The data were acquired as part of the Osteoarthritis Initiative
(OAI) pilot MR study. Each knee was imaged twice with each
coil, for a total of four acquisitions, on a 3 Tesla Siemens Trio
scanner using sagittal 3D DESS (0.365mm x 0.456mm, 0.7mm
slice thickness, TR 16.5msec, TE 4.7msec).
The MR images were analysed using a semi-automated cartilage
segmentation software that provided measurements of cartilage
volume, thickness, and surface area. We performed two analy-
ses. To test the hypothesis that a non-uniform receive (phased
array) coil could be used to segment cartilage, the “intra coil”
reproducibility was determined using duplicate scans from the
same coil. Scans for the intra coil reproducibility were read in a
paired manner whereby the reader was unblinded to patient for
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each scan. The root-mean square coefﬁcient of variation (RMS
CV) was used as metric to qualify the reproducibility.
To test the equivalence of the two coils we examined the corre-
lation of the cartilage measures between the two coils using a
Bland-Altman analysis as well as a linear regression ﬁt. For this
test the readers were fully blinded to patient identity and images
were analyzed in a random order.
Results: The “intra coil” comparison RMS-CV ranged from 0.52
to 4.5% for the quadrature (QUAD) coil and from 0.73 to 3.59 for
the phased array (PA) coil. (Table 1) For the inter coil comparison
the R squared values ranged from 0.74 to 0.97. (Table 2) The PA
coil was found to have systematically slightly larger values than
the QUAD coil.
Table 1: Intra coil reproducibility (RMS CV)
Coil: region Volume Bone surface Cartilage surface Thickness
(mm3) area (mm2) area (mm2) (mm)
QUAD: Femur 1.56 0.93 0.52 1.65
QUAD: Medial Tibia 2.2 4.5 1.11 2.59
QUAD: Lateral Tibia 1.63 2.63 0.93 1.29
QUAD: Patella 1.8 1.69 1.07 1.88
PA: Femur 1.64 2.1 1.56 1.09
PA: Medial Tibia 1.77 3.59 0.73 2.07
PA: Lateral Tibia 1.85 2.66 0.95 1.57
PA: Patella 1.78 3.39 2.79 2.37
Table 2 inter coil comparison (R squared from linear regression ﬁt)
Region Volume Bone surface Cartilage surface Thickness
area area
Femur 0.90 0.84 0.87 0.74
Medial Tibia 0.91 0.91 0.82 0.92
Lateral Tibia 0.96 0.82 0.86 0.91
Patella 0.97 0.93 0.93 0.95
Conclusions: Neither coil had systematically lower reproducibil-
ity values, which suggests that a phased array coil can be used to
segment cartilage robustly. There was also excellent agreement
between measurements made by both coils indicating that either
coil can be used in a clinical trial for robust quantitative analysis
of cartilage.
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Purpose: T1rho MRI is an unconventional contrast mechanism
and is used to quantitatively assess proteoglycan loss in hu-
man articular cartilage. T1rho relaxation times are signiﬁcantly
elevated among patients with early OA compared to normal con-
trols and T1rho has detected trauma-induced cartilage changes
not seen with conventional MRI. However, the lack of a pulse
sequence for rapid 3D T1rho imaging is an obstacle to its imple-
mentation in clinical OA trials. Rapid (< 2 minutes), isotropic, 3D
T1rho images have not previously been obtained because of low
SNR, nonselective pulse excitation and the need for equilibrium
magnetization recovery. Here, using a T1rho-prepared b-SSFP
pulse sequence, we present the ﬁrst isotropic 3D T1rho images
of the knee joint at 1 mm cubic resolution in 2 minutes.
Methods: The pulse sequence for rapid 3D T1rho MRI consists
of an inversion recovery (TI = 1700) preparatory period designed
to null joint space ﬂuid, spectrally selective fat saturation, T1rho
preparation, and magnetization readout with a centrically en-
coded balanced steady-state free precession (b-SSFP) pulse
train (Npulses = 128), followed by a recovery delay (Figure 1).
The pulse sequence is repeated for each slice encode (Nslice
= 20 or 36) for a total scan duration of 2 or 3:30 min. Images
were obtained with an 8-channel transmit/receive parallel RF coil
(InVivo) on a 1.5 T Siemens Sonata with the following imaging
parameters: TE/TR/FLIP = 3.7/7.4 ms/30 deg, matrix = 256x128,
interpolated to 256x256x40 (or 72), resolution = 1 mm3, TDELAY
= 6 s, BW = 130 Hz/pixel. 5 scans with varying T1rho-preparation
periods (TSL = 2, 10, 20, 30 and 40 ms) were used to obtain
a T1rho relaxation map. Elliptical regions-of-interest were manu-
ally drawn to calculate mean T1rho in the superﬁcial, middle and
deep zones (ImageJ).
Figure 1
Results: Two representative axial slices from an isotropic 1
mm cubic T1rho map of the patellofemoral knee joint for two
asymptomatic subjects ages 32 and 29 (Figure 2A and 2B).
While (A) depicts normal appearing, laminar, articular cartilage,
(B) has elevated T1rho in the middle zone and 2 distinct regions
of elevated T1rho in the deep zone (white arrows). In these
two regions T1rho is higher by ∼20 ms (T1rhodeep = 25 ms
and T1rhoelevation = 45-49 ms). Since the scan duration is
proportional to Nslices, acquisitions with Nslices > 80 (total
acquisition time for 1 T1rho map = 20 minutes) are the current
limit on an acceptable scan duration. We are currently exploring
3D knee joint reconstruction in all three planes with an extended
matrix size.
Figure 2
Conclusions: Rapid, isotropic, 3D T1rho imaging was achieved
using a T1rho-prepared b-SSFP sequence, advancing the use
of T1rho imaging for clinical OA trials. Elevated T1rho values
were observed in the middle and deep zones of a single asymp-
tomatic subject, reﬂecting possible swelling and cartilage lesions,
respectively.
